Poster exhibition
Clinical and diagnostic virology

Programme

• • Poster
  • P 378

  Droplet digital PCR: A powerful tool for accurate detection of hepatitis D virus (HDV) RNA and improvement of patient management

  • Dr. Esmeralda Valiente (Berlin / DE)

   Clinical and diagnostic virology
• • Poster
  • P 379

  A decade of data-driven External Quality Assessment (EQA) through QCMD: Performance over time of molecular diagnostics for transplant-associated viruses

  • Dr. Oliver Donoso Mantke (Berlin / DE)

   Clinical and diagnostic virology
• • Poster
  • P 380

  Non-Structural protein 1-Antibody responses for the differentiation between Usutu and west nile virus infections

  • Lena Damroka Roßbacher (Vienna / AT)

   Clinical and diagnostic virology
• • Poster
  • P 382

  SARS-CoV-2 Infections with gastrointestinal symptoms elicit antibodies that achieve higher avidity as compared to infections without gastrointestinal symptoms

  • Dr. Wegene Borena (Innsbruck / AT)

   Clinical and diagnostic virology
• • Poster
  • P 383

  Universally applicable, short-term cell culture-based assays for the detection of infectious virus particles

  • Dr. Sevana Khaloian (Oberschleißheim / DE)

   Clinical and diagnostic virology
• • Poster
  • P 384

  Immediate emergence of drug resistance mutations in herpes simplex virus-1 after a single passage in the presence of Aciclovir

  • Lena Jaki (Freiburg / DE)

   Clinical and diagnostic virology
• • Poster
  • P 385

  Development of an Interferon-gamma release-assay for EBV-specific T cells

  • Tatjana Schwarz (Berlin / DE)

   Clinical and diagnostic virology
• • Poster
  • P 386

  NS1-based IgG FcγR Enzyme-Linked Immunosorbent Assays (ELISAs) for highly specific detection of anti – West Nile Virus (WNV) IgG antibodies in human sera

  • Dr. Christina Deschermeier (Hamburg / DE)

   Clinical and diagnostic virology
• • Poster
  • P 387

  Whole genome sequencing for the of the hepatitis C virus

  • Camilla Sophia Neuroth (Düsseldorf / DE)

   Clinical and diagnostic virology
• • Poster
  • P 388

  Scent dogs identify SARS-CoV-2-infections in respiratory samples from ferrets and hamsters

  • Dr. Claudia Schulz (Hannover / DE)

   Clinical and diagnostic virology
• • Poster
  • P 389

  Proof of high stability and reproducibility of quantitative PCR results of HBV, HCV and HIV positive samples and the relevance for look back testing in hemovigilance

  • Dr. Benjamin Marx (Frankfurt / DE)

   Clinical and diagnostic virology
• • Poster
  • P 390

  EXPANDIA – Expanding access to sustainable diagnosis for infectious diseases in Africa

  • Dr. Tea Carletti (Trieste / IT)

   Clinical and diagnostic virology
• • Poster
  • P 391

  Establishment of a fluorescence-based monkeypox virus neutralization assay

  • Clemens Bodenstein (Berlin / DE)

   Clinical and diagnostic virology
• • Poster
  • P 392

  Synthetic notch receptor-based virus sensing and neutralization: A versatile tool for virological research

  • Antonia Senninger (Regensburg / DE)

   Clinical and diagnostic virology
• • Poster
  • P 393

  Development of a Triplex-Assay to quantify proviral intact and total HIV-1 DNA in CD4-cell isolates for diagnostic purposes

  • David Mwangi (Berlin / DE)

   Clinical and diagnostic virology
• • Poster
  • P 394

  Towards utilizing the HERV-H Envelope protein as a potential tumor marker

  • Jasmin Gille (Regensburg / DE)

   Clinical and diagnostic virology
• • Poster
  • P 395

  Construction and characterization of a recombinant African swine fever virus expressing secreted nanoluciferase.

  • Maksym Samoilenko (Mittelhäusern / CH)
  • Kemal Mehinagic (Mittelhäusern / CH)
  • Dr. Matthias Liniger (Mittelhäusern / CH)
  • Nicolas Ruggli (Mittelhäusern / CH)

   Clinical and diagnostic virology
• • Poster
  • P 396

  Clinical spectrum of acute human parvovirus B19 infections in pediatric patients with spherocytosis: A case series

  • Dr. Sandra Hauka (Düsseldorf / DE)

   Clinical and diagnostic virology
• • Poster
  • P 397

  Reactivity to discriminatory SARS-CoV-2 spike epitopes represents a novel clinical biomarker for post‑COVID syndrome

  • Clara Luzia Magnus (Regensburg / DE)

   Clinical and diagnostic virology
• • Poster
  • P 398

  Evaluation of the performance of the NeuMoDx MPXV Test

  • Dr. Martin Obermeier (Berlin / DE)

   Clinical and diagnostic virology
• • Poster
  • P 399

  Management of accidental live vaccination in acute lymphoblastic leukemia

  • Svenja Feldmann (Munich / DE)

   Clinical and diagnostic virology
• • Poster
  • P 400

  tANCHOR, a cell-based assay for SARS-CoV-2 neutralizing antibodies that is rapidly adaptive to various receptor-binding domains

  • Professor Norbert Bannert (Berlin / DE)

   Clinical and diagnostic virology
• • Poster
  • P 401

  Release of protein or peptide from the cell surface utilizing the tANCHOR system

  • Professor Norbert Bannert (Berlin / DE)

   Clinical and diagnostic virology
• • Poster
  • P 402

  Guardians of the gateway: Mucosal antibodies limiting SARS-CoV-2 shedding

  • Dr. Olha Puhach (Geneva / CH)

   Clinical and diagnostic virology
• • Poster
  • P 403

  Longitudinal assessment of T cell immunity to SARS-CoV-2 following a fourth COVID-19 vaccine dose using a whole blood-based IFN-gamma release assay

  • Johannes Rätz (Würzburg / DE)

   Clinical and diagnostic virology
• • Poster
  • P 404

  High plasma interleukin-6 level, but not IL-6 gene variants, as a predictive marker for the development of hepatocellular carcinoma in a Moroccan population

  • Ikram-Allah Tanouti (Casablanca / MA)

   Clinical and diagnostic virology
• • Poster
  • P 405

  Development of an RT-qPCR assay for the detection of HCMV-specific T-cells in small blood volumes

  • Dr. Benedikt Asbach (Regensburg / DE)

   Clinical and diagnostic virology
• • Poster
  • P 406

  Comparisons of two syndromic multiplex and three miniplex panel tests for the detection of viruses causing upper respiratory tract infections

  • Dr. Katharina Grikscheit (Frankfurt / DE)

   Clinical and diagnostic virology
• • Poster
  • P 407

  A PanFilo assay to match all EboV species and Marburgviruses

  • Dr. Kim Heimsch (Berlin / DE)

   Clinical and diagnostic virology
• • Poster
  • P 408

  Solutions for quantifying cytopathic effects after viral infection in vitro

  • Rosemarie Preyer (Strassberg / DE)

   Clinical and diagnostic virology
• • Poster
  • P 409

  Next generation sequencing with Oxford Nanopore to monitor virus quasispecies in recombinant arenavirus vectors for immunotherapies

  • Dr. Sarah Schmidt (Vienna / AT)

   Clinical and diagnostic virology
• • Poster
  • P 410

  Novel approach to assess parvovirus disinfection efficacy by aptamer-based assay

  • Md Anik Ashfaq Khan (Leipzig / DE)

   Clinical and diagnostic virology
• • Poster
  • P 411

  Comparison of two diagnostic methods (T-Spot COVID versus QuantiFERON SARS-CoV-2) for the qualitative detection of T-cell-mediated immunity following SARS-CoV-2 infection or vaccination

  • Jana Pillen (Halle (Saale) / DE)

   Clinical and diagnostic virology
• • Poster
  • P 412

  A comprehensive analysis of the reactivation of human polyomaviruses in patients following allogenic hematopoietic stem cell transplantation

  • Dr. Tuna Toptan (Frankfurt / DE)

   Clinical and diagnostic virology
• • Poster
  • P 413

  Roypretoviruses (order Nidovirales) as causative agents of fatal respiratory diseases of pythons (Pythonidae)

  • Dr. Dennis Rubbenstroth (Greifswald - Insel Riems / DE)

   Clinical and diagnostic virology
• • Poster
  • P 414

  Detection of pulmonary embolism in patients hospitalized with COVID-19: A comparison of conventional predictive scores and a neural network model

  • Dr. Jakob Vielhauer (München / DE)

   Clinical and diagnostic virology